Episode 558: Persistent Infection, Molecular Mimicry, and the Future of Chronic Lyme | Amy Proal, PhD
14 March 2026

Episode 558: Persistent Infection, Molecular Mimicry, and the Future of Chronic Lyme | Amy Proal, PhD

Tick Boot Camp

About

In this powerful and science-forward episode of the Tick Boot Camp Podcast, host Matt Sabatello sits down with Amy Proal, PhD, a leading microbiologist whose work is reshaping how the medical community understands chronic Lyme disease, post-treatment Lyme disease (PTLD), ME/CFS, and Long COVID.


Dr. Proal brings a rare combination of deep scientific expertise, lived experience with chronic illness, and real-world clinical integration, offering listeners clarity on why so many patients remain sick long after standard treatment ends — and what science is finally doing about it.


👩‍🔬 About Amy Proal, PhD

Amy Proal, PhD, is an internationally recognized microbiologist specializing in the molecular mechanisms by which persistent pathogens alter human immunity, metabolism, and gene expression.


She currently serves in two major leadership roles:




    President & Research Director,
    PolyBio Research Foundation




    Scientific Director,
    Cohen Center for Recovery from Complex Chronic Illness (CORE)
    at Mount Sinai




Her work focuses on infection-associated chronic illness, including:




    Chronic Lyme disease & tick-borne co-infections




    Post-treatment Lyme disease syndrome (PTLD)




    ME/CFS




    Long COVID




Dr. Proal is widely known for helping shift the scientific narrative away from psychosomatic explanations and toward biological root causes driven by persistent infection and immune dysregulation.


🧬 PolyBio Research Foundation: Rewriting the Science of Chronic Illness

Dr. Proal co-founded PolyBio Research Foundation in 2018 alongside neuroscientist Dr. Michael VanElzakker, after recognizing that most chronic illness research ignored root cause biology, particularly infection.


What Makes PolyBio Different


    Led by scientists, not administrators




    Focused on tissue-based research, not just blood tests




    Actively recruits researchers from HIV, tuberculosis, and virology fields to study Lyme and ME/CFS




    Designs research programs
    before
    fundraising, ensuring scientific rigor




PolyBio has played a major role in advancing research on:




    Pathogen persistence in human tissue




    Hidden reservoirs of infection




    Why standard diagnostics often fail





🏥 Cohen Center for Recovery from Complex Chronic Illness (CORE)

Dr. Proal also serves as Scientific Director of the Cohen Center for Recovery from Complex Chronic Illness (CORE) at Mount Sinai in New York City.


CORE’s Mission


    Treat patients with Long COVID and chronic tick-borne illness within an insurance-based system




    Integrate clinical care with active research and clinical trials




    Establish new standards of care for infection-associated chronic disease




At CORE, Dr. Proal helps design studies that leverage real patient visits — asking critical questions such as:




    Where is the pathogen hiding?




    What tissues are affected?




    What immune pathways are disrupted?





🧠 Persistent Infection & Why Blood Tests Fail

A central theme of the episode is that chronic infection is often a tissue-based disease, not a blood-based one.


Dr. Proal explains:




    Pathogens like Borrelia (Lyme) and SARS-CoV-2 actively avoid the bloodstream




    Blood is heavily patrolled by immune cells — tissue offers protection




    Absence of evidence in blood ≠ absence of infection




This helps explain why:




    Lyme disease often goes undetected by standard serology




    Patients remain symptomatic despite “negative tests”




    Tissue biopsies and advanced imaging are essential for progress





🧬 Molecular Mimicry: How Infection Triggers Autoimmune Symptoms

Dr. Proal provides a clear explanation of molecular mimicry, a key mechanism linking infection and autoimmunity.


What Is Molecular Mimicry?


    Pathogens produce proteins that closely resemble human proteins




    The immune system attacks the pathogen — and accidentally attacks the body




    This creates autoimmune-like disease, even though infection is the trigger




This mechanism helps explain:




    Why immune suppression may reduce symptoms but worsen disease




    Why many autoimmune diagnoses may actually be infection-driven




    Why treating the pathogen matters, not just calming the immune system




🔁 Successive Infection: Why Some Patients Get Sicker Than Others

A major insight from this episode is Dr. Proal’s concept of successive infection.


Rather than genetics alone, she suggests severity is often driven by:




    Prior infections (Lyme, Bartonella, Babesia, viruses)




    Environmental exposures (mold, toxins)




    Physical trauma (concussions, brain injury)




Each “hit” dysregulates the immune system, making the next infection harder to clear — a cumulative burden that explains why:




    Some people become severely ill from Lyme




    Others remain asymptomatic despite repeated tick exposure




🧠 Neurological Lyme, the Brain & the Vagus Nerve

Dr. Proal discusses multiple ways Lyme and infections affect the nervous system:


Direct CNS Infection


    Pathogens crossing the blood–brain barrier




    Microglial activation causing neuroinflammation




Indirect Neurological Signaling


    Infection in the gut, heart, or lungs activating the vagus nerve nearby




    Direct infection of the vagus nerve with Lyme




    Brainstem signaling triggering fatigue, pain, dysautonomia, and brain fog




This dual-pathway model explains why neurological symptoms can occur even without detectable brain infection.


🧫 Tissue, Imaging & the Future of Diagnostics

One of the most exciting parts of the episode covers next-generation diagnostics, including:




    Tissue biopsies (gut, lymph nodes, nerve, synovium)




    Ultra-sensitive molecular detection




    Immune cell exhaustion markers (e.g., PD-1)




    Advanced imaging that can map pathogens in the body




Dr. Proal explains how future tools may:




    Identify not just
    presence
    , but
    activity
    of infection




    Distinguish nervous system involvement




    Enable targeted clinical trials and personalized treatment




🧠 Infection, Alzheimer’s & Neurodegenerative Disease

Dr. Proal also discusses compelling research linking infection to Alzheimer’s disease, including evidence that:




    Amyloid plaques may be part of the innate immune response




    Plaques form around viral, bacterial, and fungal pathogens




    Removing amyloid alone fails because it ignores root cause




This framework aligns with decades of overlooked research connecting Lyme, herpesviruses, and neurodegeneration.


🌱 Hope for the Lyme & Chronic Illness Community

Dr. Proal closes the episode with optimism, highlighting:




    Rapid advances in diagnostics




    Better-designed clinical trials




    Increasing collaboration across institutions




    A long-overdue shift toward biological validation




Her message is clear: Patients were right. Science is finally catching up.


🔑 Key Topics Covered


    Chronic Lyme disease




    Post-treatment Lyme disease syndrome (PTLD)




    Persistent Borrelia infection




    Molecular mimicry and autoimmunity




    Successive infection model




    Long COVID pathogen persistence




    Tissue-based diagnostics




    Neurological Lyme disease




    Vagus nerve and dysautonomia




    Cohen Center for Recovery from Complex Chronic Illness




    PolyBio Research Foundation